[HTML][HTML] The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
H Akamatsu, K Ninomiya, H Kenmotsu… - International journal of …, 2019 - Springer
… According to rapid development of chemotherapy in advanced non-small cell lung cancer
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually since …
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually since …
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival …
Y Kawashima, T Fukuhara, H Saito… - The Lancet …, 2022 - thelancet.com
… The JO25567 study was a randomised, multicentre, phase 2 trial that compared
bevacizumab–erlotinib with erlotinib alone as first-line treatments in 154 Japanese patients with …
bevacizumab–erlotinib with erlotinib alone as first-line treatments in 154 Japanese patients with …
… in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010
…, Japanese Joint Committee of Lung Cancer … - Journal of Thoracic …, 2019 - Elsevier
… This study demonstrates improved surgical results for lung cancer in Japan. The TNM
revision for the eighth edition was supported by the assessment of stage migration from the …
revision for the eighth edition was supported by the assessment of stage migration from the …
Profiling preexisting antibodies in patients treated with anti–PD-1 therapy for advanced non–small cell lung cancer
Y Toi, S Sugawara, J Sugisaka, H Ono… - JAMA …, 2019 - jamanetwork.com
… The expression levels of PD-L1 were not routinely assayed in the present study because no
diagnostic kits were commercially available in Japan at the time. Therefore, we were unable …
diagnostic kits were commercially available in Japan at the time. Therefore, we were unable …
Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases
…, Japanese Joint Committee of Lung Cancer … - The Annals of thoracic …, 2021 - Elsevier
… 13,951 patients with nonsquamous non-small cell lung cancer included in this study, 5780
patients (… in a large cohort of Japanese patients with surgically treated lung adenocarcinoma …
patients (… in a large cohort of Japanese patients with surgically treated lung adenocarcinoma …
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised …
H Saji, M Okada, M Tsuboi, R Nakajima, K Suzuki… - The Lancet, 2022 - thelancet.com
… -stage lung cancer is only indicated for selected patients with … 90s in Japan, the early detection
of small-sized early lung … is a highly malignant disease, according to our results, patients …
of small-sized early lung … is a highly malignant disease, according to our results, patients …
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
K Nakagawa, T Hida, H Nokihara, M Morise, K Azuma… - Lung Cancer, 2020 - Elsevier
… The J-ALEX study compared the efficacy and safety of alectinib with crizotinib in Japanese
patients with advanced ALK-positive non-small-cell lung cancer (NSCLC). Superiority in …
patients with advanced ALK-positive non-small-cell lung cancer (NSCLC). Superiority in …
… pemetrexed followed by maintenance pemetrexed with docetaxel monotherapy in elderly patients with advanced nonsquamous non–small cell lung cancer: a phase 3 …
I Okamoto, H Nokihara, S Nomura, S Niho… - JAMA …, 2020 - jamanetwork.com
… Our Japan-specific trial may limit the generalizability of the results, since all enrolled
participants are Japanese patients with NSCLC who usually show better survival than Western …
participants are Japanese patients with NSCLC who usually show better survival than Western …
Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients
T Morishima, Y Matsumoto, N Koeda… - Journal of …, 2019 - jstage.jst.go.jp
… in Japanese patients diagnosed with major solid tumors. Methods: To obtain patient-level …
population-based cancer registry data from Osaka Prefecture, Japan and administrative data …
population-based cancer registry data from Osaka Prefecture, Japan and administrative data …
[HTML][HTML] A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
…, H Asamura, West Japan Oncology Group… - The Journal of thoracic …, 2022 - Elsevier
… To select lung cancer that has no nodal involvement or lymphovascular invasion, the Japan
… The study defined radiologic noninvasive lung cancer as lung cancer 2 cm or less in size …
… The study defined radiologic noninvasive lung cancer as lung cancer 2 cm or less in size …
相关搜索
- survival data for patients lung cancer
- crizotinib in patients lung cancer
- older patients lung cancer
- cell lung cancer
- elderly patients lung cancer
- phase 3 trial lung cancer
- japanese lung cancer registry study
- sublobar resection lung cancer
- american society lung cancer
- surgically treated lung adenocarcinoma japanese patients
- pembrolizumab in patients lung cancer
- non-small cell lung cancer prognostic assessment
- practice guideline update lung cancer
- weekly docetaxel lung cancer
- ground glass lung cancer
- small cell lung cancer performance status